Niva Bupa Health Insurance Company
Market cap ₹13,658 Cr
- P/E
- 25.71
- Day range
- ₹72.75 – ₹76.01
- 52-week range
- ₹67.50 – ₹91.40
- Volume
- 20.58 L
- Open
- ₹75.99
- Prev close
- ₹75.59
Latest results · Q2 FY27(consolidated)Revenue ₹2,412 Cr+58.7%Profit ₹136 CrMargin 5.6%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
NIVABUPA in NSE indices and F&O
Research profile
Composite 59 / 100Factor percentiles
Derived metrics
- Earn. yield
- 3.9%
- 12-1 mom.
- -0.1%
- Return / vol
- -0.12
- FCF yield
- 6.3%
Appears in 14 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 11 in Insurance| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Life Insurance CorpLICI | ₹2.53 L Cr | 8.15 | 2.67 | 37.8% | 35.0% | 4.1% | 0.00 | +9.9% |
| SBI Life InsuranceSBILIFE | ₹1.79 L Cr | 67.57 | — | 13.7% | 15.0% | 2.3% | 0.00 | +6.5% |
| HDFC Life InsuranceHDFCLIFE | ₹1.25 L Cr | 60.77 | 6.61 | 11.3% | 10.0% | 1.4% | 0.16 | +18.3% |
| ICICI Lombard GICICICIGI | ₹82,272 Cr | 32.34 | 4.49 | 17.8% | 22.0% | 15.0% | 0.00 | +19.7% |
| ICICI Life InsuranceICICILIFE | ₹64,485 Cr | 36.69 | 4.85 | 12.6% | 10.0% | -24.0% | 0.19 | -79.7% |
| General Insurance Corporation of IndiaGICRE | ₹59,413 Cr | 6.62 | 0.80 | 14.6% | 17.0% | 23.0% | 0.00 | +17.5% |
| Max Financial ServicesMFSL | ₹49,034 Cr | 264.58 | 8.60 | 2.0% | 3.0% | 1.2% | 0.35 | +18.5% |
| Niva Bupa Health Insurance CompanyNIVABUPA | ₹13,658 Cr | 25.71 | — | 3.5% | 3.0% | 7.0% | 0.07 | +25.5% |
| Sector median | ₹59,413 Cr | 32.34 | 4.67 | 11.3% | 10.0% | 2.3% | 0.01 | +17.1% |
Sector as classified in the tracked universe; medians use every tracked Insurance company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 2h agoHeadlines about Niva Bupa Health Insurance Company from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- ROE (FY26)
- 3.5%
- ROCE (latest year)
- 3%
Moving averages (NSE)
- 20-day
- ₹74.59
- Price below
- 50-day
- ₹76.69
- Price below
- 200-day
- ₹79.42
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- DII
- Public
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Financial statements
| Line item | Dec 2023 (S) | Mar 2024 (S) | Jun 2024 (S) | Sep 2024 (S) | Dec 2024 (S) | Mar 2025 (S) | Jun 2025 (S) | Sep 2025 (S) | Dec 2025 (S) | Mar 2026 (S) | Jun 2026 (S) | Sep 2026 (S) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,026 | 1,316 | 1,124 | 1,321 | 1,258 | 1,671 | 1,932 | 2,049 | 1,611 | 2,251 | 2,471 | 2,572 |
| Expenses | 1,071 | 1,215 | 1,228 | 1,387 | 1,282 | 1,420 | 1,834 | 1,967 | 1,705 | 2,069 | 2,287 | 2,389 |
| Operating Profit | -46 | 100 | -103 | -66 | -24 | 251 | 98 | 82 | -94 | 182 | 184 | 183 |
| OPM % | -4.4% | 8% | -9% | -5% | -1.9% | 15% | 5% | 4% | -6% | 8% | 7% | 7% |
| Other Income | 50 | 57 | 84 | 79 | 37 | -45 | 0 | 0 | 7 | -1 | 0 | -2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 5 | 157 | -19 | 13 | 13 | 206 | 98 | 82 | -88 | 181 | 184 | 182 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 27% | 26% | 0% | 12% | 25% | 25% |
| Net Profit | 5 | 157 | -19 | 13 | 13 | 206 | 71 | 61 | -88 | 159 | 138 | 136 |
| EPS in Rs | — | — | — | — | ₹0.07 | ₹1.13 | ₹0.39 | ₹0.33 | ₹-0.47 | ₹0.86 | ₹0.75 | ₹0.73 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
0 days since Mar 2021 (S)
0 days since Mar 2021 (S)
-64 days since Mar 2021 (S)
Strengths, risks & growth
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India. [1]
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 55.36% | 55.36% | 55.30% | 55.29% | -0.01 pp |
| FII | 10.31% | 10.60% | 12.09% | 12.95% | +0.86 pp |
| DII | 16.04% | 16.49% | 16.17% | 15.89% | -0.28 pp |
| Public | 18.27% | 17.56% | 16.44% | 15.88% | -0.56 pp |
Filed with NSE for Sept 2026: promoters 55.29%, public 44.71%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 9.19% (-0.16 pp)- Promoters55.3%
- Foreign institutions12.9%
- Mutual funds9.2%
- Insurance0.9%
- Other domestic institutions5.8%
- Retail1.8%
- Others14.1%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| Nippon India Multi Cap Fund | 2.62% | 0.72% | -0.08 pp |
| Axis Small Cap Fund | 1.31% | 0.64% | -0.11 pp |
| DSP Small Cap Fund | 0.89% | 0.63% | -0.13 pp |
| SBI ELSS Tax Saver Fund | 0.82% | 0.39% | -0.04 pp |
| SBI Banking & Financial Services Fund | 0.46% | 0.63% | -0.10 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Avg
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 23.9%
- Downside volatility
- 22.9%
- Worst 5% of days
- 2.4%
- Average of that tail
- 3.1%
- Max drawdown (1Y)
- 19.8%
- Below its peak
- 16.5%
Against the market
- Beta vs Nifty 50
- 0.27
- Correlation
- 0.15
- Relative strength (3M)
- -14.6%
- ATR (14)
- 3.3%
Return
- Return 1M
- -2.8%
- Return 3M
- -10.8%
- Return 6M
- -7.7%
- Return 1Y
- -2.9%
- vs 200-day average
- -7.1%
Momentum
- RSI (14)
- 43.2
- MACD histogram
- 0.21
- Stochastic %K
- 30.3
- ADX (14)
- 25.3
- +DI / −DI
- 24.5 / 22.4
- Money flow index
- 68.4
Participation
- Delivery (20d avg)
- 62.2%
- vs its 60-day baseline
- +6.1 pts
- Volume vs 20-day
- +0.6σ
- Close vs day's VWAP
- +0.2%
- 52-week position
- 27 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
No F-Score: it needs two reporting periods a year apart that carry both an income statement and a balance sheet, and this company's filings do not yet line up that way. The ratios below need only the one period and are unaffected.
- Free cash flow
- ₹856 Cr
- FCF yield
- 6.3%
- Net debt
- ₹177 Cr
- Net debt / equity
- 0.05
- EV / sales
- 1.66
- Revenue CAGR
- 58.7%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
Company announcements
Postal ballot notice along with Explanatory statement
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Completion of redemption of Debentures at par, pursuant to exercise of call option and payment of interest thereon.
Intimation - Participation in Investor Conferences
Transcript of Earnings Call held on November 04, 2026
Submission of Newspaper Publication
The Company has informed about the link of audio recording.
Press Release on unaudited financial results for the quarter and half year ended September 30, 2026
Amendments to the PIT Policies
Investor Presentation for the Earnings call scheduled today i.e. November 04, 2026.
Outcome of Board meeting held on November 04, 2026
Allotment of 9,89,450 Equity shares.
Intimation of Earning Call for the quarter and half year ended September 30, 2026
Niva Bupa Health Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited ....
Cessation of Mr. Roger William John Davis, Non-executive Director of the Company w.e.f. October 17, 2026.
Filed with BSE (scrip 544286); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlides
- Feb 2026TranscriptSlides
- Nov 2025TranscriptSlidesRecording
- Aug 2025TranscriptSlides
Credit ratings
- Rating update · 15 Oct from fitch
- Rating update · 21 Aug from icra
- Rating update · 16 Jul from icra
- Rating update · 26 Jun from care
- Rating update · 27 Jun 2025 from care
- Rating update · 2 Jul 2024 from care
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 4 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Niva Bupa Health Insurance Company: common questions
Answered from the figures on this page.